To investigate whether the ablation of IRF4 in skeletal muscles ameliorated NASH progression, we generated skeletal muscle-specific IRF4 knockout (F4MKO) mice, as previously described19. Here, IRF4 is linked to metabolic dysfunction-associated steatohepatitis.